4//SEC Filing
NOVELION THERAPEUTICS INC. 4
Accession 0001104659-17-029416
CIK 0000827809operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:01 PM ET
Size
6.2 KB
Accession
0001104659-17-029416
Insider Transaction Report
Form 4
Chan Barbara Y
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-05-01+20,000→ 20,000 totalExercise: $9.93Exp: 2027-05-01→ Common Shares (20,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 6,666 common shares underlying this stock option award will vest on May 1, 2018, 6,667 common shares underlying this stock option award will vest on May 1, 2019 and 6,667 common shares underlying this stock option award will vest on May 1, 2020.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000827809
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:01 PM ET
- Size
- 6.2 KB